Fast growing export market of plant extracts in India

India is a country with abundant plant resources According to the data of India's agricultural sector, there are about 45000 species of plant resources identified in India, accounting for about 20% of the total global plant resources; about 10% of these 45000 species have been recognized as having medicinal value After 20 years, India's policy of developing pharmaceutical plant production and plant extract processing industry has achieved fruitful results According to a report released by the Ministry of Commerce and industry of India, in the 1980s, India's total export amount of plant extracts was less than 20% of that of China's similar products, and after catching up with China last year, India ranked the third in the world It can be seen that India has made considerable achievements in the development of medicinal plant cultivation and export Recently, according to Indian media reports, in a national survey of plant resources, there are about 15000 kinds of medicinal plants in India, 1500 of which have been developed and utilized, and about 500 kinds of medicinal plants are often used as raw materials of plant extracts Great leap forward Development India has a long history of herbal use, which is called "Vedic Medicine" abroad According to the report of the Ministry of Commerce and industry of India, as of the end of 2010, a number of Vedic pharmaceutical preparation factories had been built in India, including more than 20 large-scale factories and more than 140 factories in various states According to statistics of the Ministry of Commerce and industry of India, the total output value of the plant medicine processing industry in India last year was up to 50 billion rupees, with a total of 1650 kinds of plant medicine produced India not only vigorously develops the production of Vedic pharmaceutical preparations, but also encourages and develops the production of plant extracts The Indian government has organized a group of experts in Phytomedicine to formulate new policies for the development of Indian Phytomedicine production and export The Indian government also strongly encourages non-governmental enterprises to produce and export plant extracts that meet international standards, and gives preferential policies such as export tax rebate Since then, India's plant extract industry began to develop rapidly According to the data of the Ministry of Commerce and industry of India, in the past 10 years, the average growth rate of India's plant extract export has been 12% - 15%, which belongs to the "great leap forward" speed in the international plant extract industry Currently, India exports hundreds of plant extracts, including hundreds of medicinal plant raw materials and finished products Last year, India exported about 500 million US dollars of manufactured goods, of which the proportion of medicinal flavor oil and spice plant products was very large, while the export volume of medicinal plants and manufactured goods was about more than 100 million US dollars, accounting for about 10% of the total output value of vedical industry in China Of the herbal products exported from India, 60% are processed products of unique plants in India, 30% are plant extracts, and the other 10% are Vedic pharmaceutical preparations It can be seen that Indian folk herbal preparations have been recognized by the medical community of developed countries in Europe and America, and are mainly sold to Europe and America, Pakistan, Bangladesh, Sri Lanka and other South Asian countries In contrast, Chinese patent medicines are mainly sold to Hong Kong, Macao and Taiwan, Southeast Asian countries, Japan and South Korea and other countries deeply affected by Chinese civilization Chinese patent medicine has a long way to go in terms of opening up markets in Europe and the United States According to the report of F & S, the countries that exported the most medicinal plants in 2010 were: Canada, with an export of 247.3 million US dollars; China, with an export of 209.6 million US dollars; India, with an export of 105.9 million US dollars At its peak in 2005, China exported 344.2 million US dollars of medicinal plants, but in recent years, the export volume has declined This situation is related to the general economic downturn of EU countries and the trade barrier measures that the EU set up more stringent market access rules for botanical drugs a few years ago to restrict the entry of foreign botanical drug products into Europe, which led to a sharp decrease in the export of Chinese medicinal plant raw materials to the EU India, on the other hand, skilfully avoided the trade barriers of EU medicinal plants and specialized in the US market It is reported that Indian enterprises are specialized in producing various kinds of plant extract raw materials of popular dietary supplements for Americans, such as balsam pear extract, Gymnema sylvestris extract, fenugreek extract and curcumin, which can reduce blood sugar, thus promoting the export amount of plant extract in India to increase year by year According to the statistics released by the Ministry of Commerce and industry of India, there are several kinds of raw materials for medicinal plants exported from India that are superior in the international market, such as: plantain shell, which accounts for about 70% ~ 80% of the international market; narrow leaf senna leaf, which accounts for about 60% of the international market; Huluba, which accounts for about 50% of the international market, etc China's exports of plant extracts and medicinal materials to India mainly include artemisinin and its finished products, plant pigments, and some medicinal materials such as toosendania and Eclipta, while India's exports to China are mainly the medicinal materials needed for Tibetan medicine such as saffron, Rauwolfia, Chenopodium, Eupatorium, menthol oil (the domestic enterprises need to use it to process menthol and other products), Koshi, Yuganzi, etc The local traditional Chinese medicine processing industry uses less Indian medicine Last year, the total volume of trade between China and India was more than 80 million US dollars India has become the second largest export market of plant drugs and plant extracts Due to the economic downturn, China's traditional export market of plant extracts, the United States and Japan, has retreated to India This new situation deserves the attention of the majority of Chinese medicine export enterprises In short, with the rapid development of India's national economy and the rapid development of the domestic plant medicine processing industry, India is expected to become a new export market for Chinese herbal medicine and other plant drugs and plant extracts in the future Domestic enterprises should increase the research and development of the Indian market.